/ IBM Cost Optimization
Mainframe, ELA renewals, audits, CVA, and managed-services contracts: the deals where IBM spend is decided run into the tens and hundreds of millions. Shave even 5–10% and the saving is measured in millions. UMS pairs a 25-year negotiation track record with people who sat on IBM's side of the table.
/ When IBM cost is decided
Every large IBM customer hits at least one of these every year. Each one is a point of maximum leverage, or maximum exposure if it passes unmanaged.
The first response shapes the final number. We rebuild the entitlement facts (PVU, sub-capacity, ILMT gaps) before you reply, and challenge claims that run ahead of the evidence.
Related work →The "free" Client Value Acceleration (CVA) review is a soft audit. Someone pays for it, usually out of your license shortfall. Talk to us before you sign up.
ELAs renew roughly every three years, usually in December. Commit blind and you lock in a $10–30M+ spend on IBM's terms. Ask one question first: when is the renewal?
Most estates run z15 or z16 and are under pressure to move to z17. These refreshes start in the tens of millions over five years. Know the number before IBM frames it.
A $50–100M outsourcing agreement you touch once every several years; we benchmark them monthly. We bring the current numbers to a table you rarely get to see.
Capacity and monthly license charges are the classic boat anchor. Optimization here is usually the largest, least-touched saving in the entire IBM estate.
Related work →/ Scope
IBM software is expensive by design. The same expertise that defends an audit reads an ELA, sizes a refresh, and finds the waste in a distributed estate. Don't get stuck only on the mainframe: the wider IBM footprint is where a lot of the money hides.
/ The CVA trap
IBM's CVA program is sold as help getting your house in order. In practice it's a soft audit, and we have never seen an organization join without paying. We can step in before, during, or after.
We reconstruct your license position first, so the "self-audit" can't surface a shortfall you never saw coming, and you keep the leverage.
If CVA has already come back with a multi-million shortfall, we challenge the measurement and the math, and bring the settlement down.
We run the ongoing license management so you can exit CVA, keep your house in order, and stop paying IBM to audit you every quarter.
/ Why UMS
The practice pairs UMS's negotiation track record with people who were IBM auditors, account managers, resellers, and tool-vendor specialists. Often the exact expertise that was across the table from you a year or two ago.
A large organization navigates an ELA, a refresh, or a managed-services renewal every few years. We work them constantly, so you negotiate against current benchmarks, not a three-year-old memory.
Every position comes off a spreadsheet we can defend (entitlements, deployment, measurement), not a number pulled from the air. That is what makes the savings stick under pressure.
/ Proof
Everyone is interested in saving millions. They believe it when there's detail behind it. These are documented engagements, with references available.
A Fortune 500 financial-services firm challenged a $100M IBM settlement letter and cut the demand 90%+.
Read the IBM audit case → 1,170 → 50 PVUA global capital-markets platform cut a modeled IBM MQ licensing gap 96% before a virtualization overbuy.
Read the IBM MQ case → $800M+Saved for the City of New York across IBM and the wider software estate, with named, referenceable outcomes.
Read the NYC case →/ Start here
That one question usually tells us whether there's a saving on the table. Book a free 30-minute diagnostic: we'll review your IBM position and show you where the money is, with no retainer and no obligation.
/ How UMS is paid
/ FAQ
Anything on IBM paper: mainframe hardware and software (MLC and IPLA), MIPS and capacity, Enterprise License Agreements and Passport Advantage, distributed products such as Db2, Cognos, MQ, WebSphere, Maximo and Sterling, Red Hat, IBM Cloud, and managed-services contracts with providers like Kyndryl or Tata. If it has IBM on the brand, it is in scope.
CVA (Client Value Acceleration) is IBM's self-audit program, the evolution of the earlier IASP (IBM Authorized SAM Provider) program. IBM frames it as a "free" optimization service, but it is delivered through one of four IBM-authorized providers (Anglepoint, Deloitte, EY, KPMG), several of them the same firms that run IBM audits, and any shortfall it surfaces still has to be bought back from IBM. It can be the right move for some organizations, but talk to us before you sign so you go in with your position already prepared, not exposed.
Both. Mainframe MIPS, capacity, MLC, and hardware-refresh negotiations (z15/z16 to z17) are often the single largest savings opportunity. Distributed estates (Db2, Cognos, MQ, Maximo, Sterling) and the ELA that ties them together are equally in scope.
Usually, yes. Most mainframe savings come from right-sizing license commitments, tuning workloads to lower MSU peaks, moving to the best-fit pricing model, and challenging IBM's projected MSU growth, not from removing capacity the business depends on. The aim is a lower bill for the same service.
Before a compelling event, not after. The strongest moments are an upcoming ELA renewal, a hardware refresh, a managed-services renegotiation, a CVA invitation, or an audit letter. For an ELA, start 9 to 12 months before the renewal date: that lead time is what buys the data, the scenarios, and the leverage. If you know your IBM renewal date, that is the conversation to start now.
For most work, zero upfront: UMS is paid from the savings achieved. Depending on how clearly the baseline can be established, engagements run as shared-savings, fixed-fee, or a fixed fee plus a performance bonus tied to exceeding a target.
Updated May 2026